Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
1Department of Clinical Psychology, VU University Amsterdam, The Netherlands (Нидерланды); 2EMGO Institute for Health and Care Research, VU University and VU University Medical Center Amsterdam, The Netherlands (Нидерланды); 3Leuphana University, Lunebrug, Germany (Германия); 4Department of Behavioural Sciences and Learning, Swedish Institute for Disability Research, University of Linkoping, Sweden (Швеция); 5Department of Clinical Neuroscience, Psychiatry Section, Karolinska Institute, Stockholm, Sweden (Швеция); 6Department of Psychiatry, VU University Medical Center Amsterdam, The Netherlands; 7department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA (США)
Список исп. литературыСкрыть список 1. Kessler RC, Berglund P, Demler O et al. National Comorbidity Survey Replication. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003;289:3095-105. 2. Kessler RC, Berglund P, Demler O et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62: 593-602. 3. Ustun TB, Ayuso-Mateos JL, Chatterji S et al. Global burden of depressive disorders in the year 2000. Br J Psychiatry 2004;184: 386-92. 4. Saarni SI, Suvisaari J, Sintonen H et al. Impact of psychiatric disorders on health-related quality of life: general population survey. Br J Psychiatry 2007;190:326-32. 5. Berto P, D’Ilario D, Ruffo P et al. Депрессия: cost-of-illness studies in the international literature: a review. J Ment Health Policy Econ 2000;3:3-10. 6. Greenberg PE, Birnbaum HG. The economic burden of depression in the US: societal and patient perspectives. Exp Opin Phar- macother 2005;6:369-76. 7. Smit F, Cuijpers P, Oostenbrink J et al. Excess costs of common mental disorders: population based cohort study. J Ment Health Policy Econ 2006;9:193-200. 8. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3:e442. 9. National Institute for Health and Clinical Excellence (NICE). Depression; the treatment and management of depression in adults. Holborn: NICE, 2009. 10. Bauer M, Bschor T, Pfennig A et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders in primary care. World J Biol Psychiatry 2007;8:67-104. 11. Bandelow B, Sher L, Bunevicius R et al. Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care. Int J Psychiatry Clin Pract 2012;16:77-84. 12. Cuijpers P, Sijbrandij M, Koole SL et al. The efficacy of psychotherapy and pharmacotherapy in treating depressive and anxiety disorders: a meta-analysis of direct comparisons. (World Psychiatry 2013;12:137-48) 13. Cuijpers P, Dekker J, Hollon SD et al. Adding psychotherapy to pharmacotherapy in the treatment of depressive disorders in adults: a meta-analysis. J Clin Psychiatry 2009;70:1219-29. 14. Cuijpers P, van Straten A, Warmerdam L et al. Psychological treatment versus combined treatment of depression: a meta-analysis. Depress Anx 2009;26:279-88. 15. de Maat SM, Dekker J, Schoevers RA et al. Relative efficacy of psychotherapy and combined therapy in the treatment of depression: a meta-analysis. Eur Psychiatry 2007;22:1-8. 16. Olfson M, Marcus SC. National trends in outpatient psychotherapy. Am J Psychiatry 2010;167:1456-63. 17. Marcus SC, Olfson M. National trends in the treatment for depression from 1998 to 2007. Arch Gen Psychiatry 2010;67:1265-73. 18. Furukawa TA, Watanabe N, Churchill R. Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia. Cochrane Database of Systematic Reviews 2007 (1): CD004364. 19. Hofmann SG, Sawyer AT, Korte KJ et al. Is it beneficial to add pharmacotherapy to cognitive-behavioral therapy when treating anxiety disorders? A meta-analytic review. Int J Cogn Ther 2009; 2:160-75. 20. Higgins JPT, Green S (eds). Cochrane handbook for systematic reviews of interventions. Version 5.0.1. Oxford: Cochrane Collaboration, 2008. 21. Hedges LV, Olkin I. Statistical methods for meta-analysis. San Diego: Academic Press, 1985. 22. Kraemer HC, Kupfer DJ. Size of treatment effects and their importance to clinical research and practice. Biol Psychiatry 2006;59:990-6. 23. Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. N Engl J Med 1988;318:1728-33. 24. Higgins JP, Thompson SG, Deeks JJ et al. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60. 25. Ioannidis JPA, Patsopoulos NA, Evangelou E. Uncertainty in heterogeneity estimates in meta-analyses. BMJ 2007;335:914-6. 26. Orsini N, Higgins J, Bottai M et al. Heterogi: Stata module to quantify heterogeneity in a meta-analysis. Boston: Boston College Department of Economics, 2005. 27. Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000;56:455-63. 28. Azhar MZ. Comparison of Fluvoxamine alone, Fluvoxamine and cognitive psychotherapy and psychotherapy alone in the treatment of panic disorder in Kelantan - implications for management by family doctors. Med J Malaysia 2000;55:402-8. 29. Barlow DH, Gorman JM, Shear MK et al. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: a randomized controlled trial. JAMA 2000;283:2529-36. 30. Bellack AS, Hersen M, Himmelhoch J. Social skills training compared with pharmacotherapy and psychotherapy in the treatment of unipolar depression. Am J Psychiatry 1981;138:1562-67. 31. Bellino S, Zizza M, Camilla R et al. Combined treatment of major depression in patients with borderline personality disorder: a comparison with pharmacotherapy. Am J Psychiatry 2006;51:253-60. 32. Berger P, Sachs G, Amering M et al. Personality disorder and social anxiety predict delayed response in drug and behavioral treatment of panic disorder. J Affect Disord 2004;80:75-8. 33. Blackburn IM, Bishop S, Glen AI et al. The efficacy of cognitive therapy in depression: a treatment trial using cognitive therapy and pharmacotherapy, each alone and in combination. Br J Psychiatry 1981;139:181-9. 34. Blanco C, Heimberg RG, Schneier FR et al. A placebo-controlled trial of phenelzine, cognitive behavioral group therapy, and their combination for social anxiety disorder. Arch Gen Psychiatry 2010;67:286-95. 35. Blom MB, Spinhoven P, Hoffman T et al. Severity and duration of depression, not personality factors, predict short term outcome in the treatment of major depression. J Affect Disord 2007;104: 119-26. 36. Blomhoff S, Haug TT, Hellstrom K et al. Randomised controlled general practice trial of sertraline, exposure therapy and combined treatment in generalised social phobia. Br J Psychiatry 2001;179:23-30. 37. Browne G, Steiner M, Roberts J et al. Sertraline and/or interpersonal psychotherapy for patients with dysthymic disorder in primary care: 6-month comparison with longitudinal 2-year follow-up of effectiveness and costs. J Affect Disord 2002;68:317-30. 38. Burnand Y, Andreoli A, Kolatte E et al. Psychodynamic psychotherapy and clomipramine in the treatment of major depression. Psychiatr Serv 2002;53:585-90. 39. Crits-Christoph P, Newman MG, Rickels K et al. Combined medication and cognitive therapy for generalized anxiety disorder. J Anxiety Disord 2011;25:1087-94. 40. Davidson JRT, Foa EB, Huppert JD et al. Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia. Arch Gen Psychiatry 2004;61:1005-13. 41. de Jonghe F, Kool S, van Aalst G et al. Combining psychotherapy and antidepressants in the treatment of depression. J Affect Disord 2001;64:217-29. 42. de Mello MF, Myczcowisk LM, Menezes PR. A randomized controlled trial comparing moclobemide and moclobemide plus interpersonal psychotherapy in the treatment of dysthymic disorder. J Psychother Pract Res 2001;10:117-23. 43. Dozois DJA, Bieling PJ, Patelis-Siotis I et al. Changes in self-schema structure in cognitive therapy for major depressive disorder: a randomized clinical trial. J Consult Clin Psychol 2009;77:1078-88. 44. Finkenzeller W, Zobel I, Rietz S et al. Interpersonal psychotherapy and pharmacotherapy for post-stroke depression. Feasibility and effectiveness. Nervenarzt 2009;80:805-12. 45. Foa EB, Liebowitz MR, Kozak MJ et al. Randomized, placebo- controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. Am J Psychiatry 2005;162:151-61. 46. Hautzinger M, de Jong-Meyer R, Treiber R et al. Wirksamkeit Kognitiever Verhaltenstherapie, Pharmacotherapie und deren Kombination bei nicht-endogenen, unipolaren Depressionen. Zeitschr Klin Psychol 1996;25:130-45. 47. Hellerstein DJ, Little SAS, Samstag LW et al. Adding group psychotherapy to medication treatment in dysthymia: a randomized prospective pilot study. J Psychother Pract Res 2001;10:93-103. 48. Hollon SD, DeRubeis RJ, Evans MD et al. Cognitive therapy and pharmacotherapy for depression: singly and in combination. Arch Gen Psychiatry 1992;49:774-81. 49. Hsiao FH, Jow GM, Lai YM et al. The long-term effects of psychotherapy added to pharmacotherapy on morning to evening diurnal cortisol patterns in outpatients with major depression. Psychother Psychosom 2011;80:166-72. 50. Keller MB, McCullough JP, Klein DN et al. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med 2000;342:1462-70. 51. King ALS, Valenca AM, de Melo-Neto VL et al. Efficacy of a specific model for cognitive-behavioral therapy among panic disorder patients with agoraphobia: a randomized clinical trial. Sao Paulo Med J 2011;129:325-34. 52. Koszycki D, Taljaard M, Segal Z et al. A randomized trial of sertraline, self-administered cognitive behavior therapy, and their combination for panic disorder. Psychol Med 2011;41:373-83. 53. Lesperance F, Frasure-Smith N, Koszycki D et al. Effects of cita- lopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA 2007;297:367-79. 54. Loerch B, Graf-Morgenstern M, Hautzinger M et al. Randomised placebo-controlled trial of moclobemide, cognitive-behavioural therapy and their combination in panic disorder with agoraphobia. Br J Psychiatry 1999;174: 205-12. 55. Lynch TR, Morse JQ, Mendelson T et al. Dialectical behavior therapy for depressed older adults: a randomized pilot study. Am J Geriatr 2003;11:33-45. 56. Macaskill ND, Macaskill A. Rational-emotive therapy plus pharmacotherapy vs. pharmacotherapy alone in the treatment of high cognitive dysfunction depression. Cogn Ther Res 1996;20: 575-92. 57. Maina G, Rosso G, Rigardetto S et al. No effect of adding brief dynamic therapy to pharmacotherapy in the treatment of obsessive-compulsive disorder with concurrent major depression. Psychother Psychosom 2010;79: 295-302. 58. Markowitz JC, Kocsis JH, Bleiberg KL et al. A comparative trial of psychotherapy and pharmacotherapy for “pure” dysthymic patients. J Affect Disord 2005;89:167-75. 59. Misri S, Reebye P, Corral M et al. The use of paroxetine and cognitive-behavioral therapy in postpartum depression and anxiety: a randomized controlled trial. J Clin Psychiatry 2004;65:1236-41. 60. Mitchell PH, Veith RC, Becker KJ et al. Brief psychosocial- behavioral intervention with antidepressant reduces poststroke depression significantly more than usual care with antidepressant: living well with stroke: randomized, controlled trial. Stroke 2009;40:3073-8. 61. Murphy GE, Simons AD, Wetzel RD et al. Cognitive therapy and pharmacotherapy. Singly and together in the treatment of depression. Arch Gen Psychiatry 1984;41:33-41. 62. Mynors-Wallis LM, Gath DH, Day A et al. Randomised controlled trial of problem solving treatment, antidepressant medication, and combined treatment for major depression in primary care. BMJ 2000;320:26-30. 63. Naeem F, Waheed W, Gobbi M et al. Preliminary evaluation of culturally sensitive CBT for depression in Pakistan: findings from Developing Culturally-sensitive CBT Project (DCCP). Behav Cogn Psychother 2011;39:165-73. 64. Otto MW, Hinton D, Korbly NB et al. Treatment of pharmacotherapy-refractory posttraumatic stress disorder among Cambodian refugees: a pilot study of combination treatment with cognitive- behavior therapy vs sertraline alone. Behav Res Ther 2003;41:1271-6. 65. Prasko J, Dockery C, Horacek J et al. Moclobemide and cognitive behavioral therapy in the treatment of social phobia. A six-month controlled study and 24 months follow up. Neuroendocrinol Lett 2006;27:473-81. 66. Ravindran AV, Anisman H, Merali Z et al. Treatment of primary dysthymia with group cognitive therapy and pharmacotherapy: clinical symptoms and functional impairments. Am J Psychiatry 1999;156:1608-17. 67. Reynolds CF 3rd, Miller MD, Pasternak RE et al. Treatment of bereavement-related major depressive episodes in later life: a controlled study of acute and continuation treatment with nortriptyline and interpersonal psychotherapy. Am J Psychiatry 1999;156: 202-8. 68. Rothbaum BO, Cahill SP, Foa EB et al. Augmentation of sertraline with prolonged exposure in the treatment of posttraumatic stress disorder. J Trauma Stress 2006;19:625-38. 69. Shamsaei F, Rahimi A, Zarabian MK et al. Efficacy of pharmacotherapy and cognitive therapy, alone and in combination in major depressive disorder. Hong Kong J Psychiatry 2008;18:76-80. 70. Shareh H, Gharraee B, Atef-Vahid MK et al. Metacognitive Therapy (MCT), fluvoxamine, and combined treatment in improving obsessive-compulsive, depressive and anxiety symptoms in patients with Obsessive-Compulsive Disorder (OCD). Iran J Psychiatry Behav Sci 2010;4:17-25. 71. Sharp DM, Power KG, Simpson RJ et al. Fluvoxamine, placebo, and cognitive behaviour therapy used alone and in combination in the treatment of panic disorder and agoraphobia. J Anxiety Dis 1996;10:219-42. 72. Sirey JA, Bruce ML, Alexopoulos GS. The Treatment Initiation Program: an intervention to improve depression outcomes in older adults. Am J Psychiatry 2005;162:184-6. 73. Spinhoven P, Onstein EJ, Klinkhamer RA et al. Panic management, trazodone and a combination of both in the treatment of panic disorder. Clin Psychol Psychother 1996;3: 86-92. 74. Tenneij NH, Megen HJ, Denys DAJP et al. Behavior therapy augments response of patients with obsessive-compulsive disorder responding to drug treatment. J Clin Psychiatry 2005;66: 1169-75. 75. Thompson LW, Coon DW, Gallagher-Thompson D et al. Comparison of desipramine and cognitive/behavioral therapy in the treatment of elderly outpatients with mild-to-moderate depression. Am J Geriatr Psychiatry 2001;9: 225-40. 76. van Apeldoorn FJ, van Hout WJPJ, Huisman M et al. Is a combined therapy more effective than either CBT or SSRI alone? Results of a multicenter trial on panic disorder with or without agoraphobia. Acta Psychiatr Scand 2008;17: 260-70. 77. Weissman MM, Prusoff BA, Dimascio A et al. The efficacy of drugs and psychotherapy in the treatment of acute depressive episodes. Am J Psychiatry 1979;136:555-8. 78. Wiborg IM, Dahl AA. Does brief dynamic psychotherapy reduce the relapse rate of panic disorder? Arch Gen Psychiatry 1996;53: 689-94. 79. Wiles NJ, Hollinghurst S, Mason V et al. A randomized controlled trial of cognitive behavioural therapy as an adjunct to pharmacotherapy in primary care based patients with treatment resistant depression: a pilot study. Behav Cogn Psychother 2008;36:21-33. 80. Katz R, Shaw BF, Vallis TM et al. The assessment of severity and symptom patterns in depression. In: Beckham EE, Leber WR (eds). Handbook of depression, 2nd ed. New York: Guilford, 1995:61-85. 81. Turner EH, Matthews AM, Linardatos E et al. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 2008;358:252-60. 82. Cuijpers P, Smit F, Bohlmeijer et al. Is the efficacy of cognitive behaviour therapy and other psychological treatments for adult depression overestimated? A meta-analytic study of publication bias. Br J Psychiatry 2010;196:173-8. 83. Friedman MA, Detweiler-Bedell JB, Leventhal HE et al. Combined psychotherapy and pharmacotherapy for the treatment of major depressive disorder. Clin Psychol Sci Pract 2004;11:47-68. 84. Otto MW, Smits JAJ, Reese HE. Combined psychotherapy and pharmacotherapy for mood and anxiety disorders in adults: review and analysis. Clin Psychol Sci Pract 2005;12:72-86.